Boardroom Radio - Straight from the source

Australia's Largest Corporate Webcaster

"Boardroom Radio brings companies to my desk. I can hear more investor briefings. Also the calendar is very useful" Matt Williams, Portfolio Manager, Perpetual

"IRESS is always seeking innovative ways to deliver relevant content to our professional user base. Webcasting is a growing and increasingly important way to communicate and we are very pleased to team with Boardroom Radio to further expand our company disclosure information." Peter Dunai, Managing Director, IRESS

"As the investment world continues to become more virtual and the reaction to the release of new investment information becomes faster, Boardroom Radio offers an easy way for all investors to access the latest information for companies." Peter Morgan, Founder 452 Capital

"Boardroom Radio will be a valuable tool to help us manage our time and connect with companies whose stories we wouldn’t normally hear" Ben Griffiths, Eley Griffiths Group

"The service from Boardroom Radio has been outstanding. To hear that we had so many listeners confirmed that Boardroom Radio is an effective communication tool." Roc Oil (ROC)

"Macquarie Airports is happy to trial new and innovative ways of increasing communication to our investors. Boardroom Radio is a particularly easy and flexible method of informing all our stakeholders of MAp's activities." Macquarie Airports (MAP)

"Boardroom Radio provides a modern, highly effective means of communicating Bonaparte's key developments to its shareholders and to a broader spectrum of the investing community in a concise and personal way." Bonaparte Diamond Mines NL

ARANA THERAPEUTICS LIMITED Audio Webcast

Loading presentation... If nothing happens, you may need to install Flash and/or enable javascript in your browser.

Loading audio... If nothing happens please either:

Click to listen to audio on your default player or

Download the latest version of the Flash Player

Audio Duration: 10:38

Dr Rob Crombie

Fri, 30 Nov 2007
11:40am Australia/Sydney

Select a tab above to display more information

Sorry, there are currently no events matching this one. Please use the search feature at the top of the page to find events.

ARANA THERAPEUTICS LIMITED (AAH)

ASX code: AAH
Website:
Industry: Pharmaceuticals, Biotechnology and Life Sciences

Principal Activities:
A biopharmaceutical company focused on developing next generation antibody based drugs that will improve the lives of patients with inflammatory diseases and cancer.

Address:
, 37 Epping Road, Level 2,
MACQUARIE PARK
NSW

Phone: 02 8061 9900
Fax: 02 8061 9999

Executives & Directors

Mr Frank Baldino , Chairman
Mr Kevin Buchi , Director
Ms Lesley Russell , Director
Mr Jeffry Vaught , Director
Mr John Hartigan , Independent Director
Mr Tony Johnson , Independent Director
Mr Niall Henderson , CFO
Mr Niall Henderson , Company Secretary

Company Podcasts

Subscribe to current and future audio events for AAH

Company ASX Announcements

Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.

Please refer to the relevant stock exchange if any of the above information is incorrect

ARANA THERAPEUTICS LIMITED (AAH) Events

Company (Stock Code)	Date/Time	Event
ARANA THERAPEUTICS LIMITED (AAH)	Mon, 15 Dec 2008 8:30am	AAH - CEO Profile - Dr Steffen Nock, Acting CEO
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 11 Dec 2008 8:30am	AAH - Arana Commences International Phase II Rheumatoid Arthritis Trial - Dr David Fuller, Chief Medical Officer
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 19 Nov 2008 9:30am	Grand Opening Melbourne Facility: Steffen Nock & Rob Crombie Speech
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 19 Nov 2008 9:00am	AAH - Grand Opening Melbourne Facility - Innovation Minister Gavin Jennings Speech
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 13 Nov 2008 3:30pm	AAH - Full Year Results 2008 - Mr Robin Beaumont, Chairman and Mr Niall Henderson, CFO
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 4 Nov 2008 8:30am	AAH - FDA Accepts Arana's Anti-Inflammatory IND - Dr David Fuller, Chief Medical Officer
ARANA THERAPEUTICS LIMITED (AAH) ART621 Reaches Key Milestone	Thu, 28 Aug 2008 4:30pm	AAH - Arana Announces Key Anti-Inflammatory Drug Milestone - Dr David Fuller, Chief Medical Officer
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 6 Aug 2008 3:45pm	AAH - 6th Annual Australian Biotechnology Summit 2008, Corporate Overview - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 3 Jul 2008 12:15pm	AAH - Grand Opening Macquarie Park Facility - Senator The Hon Kim Carr, Minister for Innovation, Industry, Science and Research
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 3 Jul 2008 12:00pm	AAH - Grand Opening Macquarie Park Facility - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 24 Jun 2008 4:00pm	AAH - Discussion on the 2008 BIO International Convention in San Diego - Dr Steffen Nock, President Arana Therapeutics Inc
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 22 May 2008 3:30pm	AAH - Arana Reports Strong Financial Position - Dr John Chiplin Managing Director, CEO and Mr Niall Henderson CFO
ARANA THERAPEUTICS LIMITED (AAH)	Mon, 28 Apr 2008 3:35pm	AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug - Dr Cliff Holloway, Vice President of Business Development
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 23 Apr 2008 12:15pm	Excellence in Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 18 Mar 2008 2:00pm	AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 18 Mar 2008 11:00am	AAH - Sky TV Update on Phase II Trial Status - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 5 Dec 2007 11:00am	AAH - Announes Phase II Trials for Lead Compound ART621 - Dr David Fuller, Chief Medical Officer
ARANA THERAPEUTICS LIMITED (AAH)	Fri, 30 Nov 2007 11:40am	AAH - Arana Therapeutics Completes Project With CSL - Dr Rob Crombie, VP Business Development
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 8 Nov 2007 11:30am	AAH - New Direction, New Name, New Future - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 9 Aug 2007 3:00pm	[PTD] PTD - Shareholders Approve Peptech-Evogenix Merger - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 14 May 2009	Interim Results
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 15 Apr 2009	Date Payable
ARANA THERAPEUTICS LIMITED (AAH)	Mon, 30 Mar 2009	Record Date
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 24 Mar 2009	Ex Div Date
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 26 Feb 2009 1:00pm	Annual General Meeting The Grace Hotel, 77 York Street, Sydney, NSW
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 11 Nov 2008 11:00pm	Full Year Results
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 13 Aug 2008 10:00am 10:00am Australia/Melbourne	Annual General Meeting The Treacy Conference Centre, 126 The Avenue, Parkville, VIC
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 21 May 2008	Interim Results
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 8 Nov 2007 11:00pm	[PTD] Full Year Results
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 17 May 2007	[PTD] Interim Results
ARANA THERAPEUTICS LIMITED (AAH)	Mon, 8 Jan 2007 9:00am	[PTD] Annual General Meeting 220 Pitt Street Sydney NSW
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 2 Nov 2006 11:00pm	[PTD] Full Year Results
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 18 May 2006	[PTD] Interim Results
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 15 Feb 2006 9:00am	[PTD] Annual General Meeting 4th Floor, 20 Bridge Street Sydney NSW 2000
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 15 Feb 2005 9:00am	[PTD] Annual General Meeting The Wesley Conference Centre, 220 Pitt Street, Sydney, NSW
Displaying 1-20 of 44 events		Display

ARANA THERAPEUTICS LIMITED (AAH)

Click here to view details on the ASX site

Removal from Official List - COB 13 August 2009	Thu, 13 Aug 2009
Final and Initial Director Interest Notices	Mon, 13 Jul 2009
Suspension from Official Quotation at close 02/07/09	Thu, 2 Jul 2009
Cephalon Takeover Bid	Tue, 30 Jun 2009
Change in substantial holding	Mon, 29 Jun 2009
Form 6021 - Compulsory Acquisition following T/O bid	Thu, 25 Jun 2009
Change in substantial holding	Tue, 23 Jun 2009
Appendix 3B - 2009 Performance Share Plan	Wed, 17 Jun 2009
Cephalon has relevant interest in 90.41% of Shares	Mon, 15 Jun 2009
Change in substantial holding	Mon, 15 Jun 2009

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.